Cargando…

SG-APSIC1095: Acquisition rate of carbapenemase-producing organisms (CPOs) among hospital contacts of CPO patients: An interim subgroup analysis of a cohort study

Objectives: The increase in carbapenemase-producing organism (CPO) transmission among hospitalized patients is a growing concern. Studies investigating the transmission of CPO to epidemiologically linked contacts are scarce. We conducted an interim subgroup analysis of the ongoing multicenter househ...

Descripción completa

Detalles Bibliográficos
Autores principales: Husen, Sharifah Farhanah Syed, Linn, Kyaw Zaw, Ong, Clara Chong Hui, Huan, Xiaowei, Loo, Liang Hui, Sazali, Ismail Bin, Vasoo, Shawn, Foo, Meow Ling, Ooi, Say Tat, Tan, Thean Yen, Smitasin, Nares, Ling, Moi Lin, Tambyah, Paul Anantharajah, Tan, Seow Yen, Ng, Oon Tek, Marimuthu, Kalisvar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571168/
http://dx.doi.org/10.1017/ash.2023.70
_version_ 1785119925705113600
author Husen, Sharifah Farhanah Syed
Linn, Kyaw Zaw
Ong, Clara Chong Hui
Huan, Xiaowei
Loo, Liang Hui
Sazali, Ismail Bin
Vasoo, Shawn
Foo, Meow Ling
Ooi, Say Tat
Tan, Thean Yen
Smitasin, Nares
Ling, Moi Lin
Tambyah, Paul Anantharajah
Tan, Seow Yen
Ng, Oon Tek
Marimuthu, Kalisvar
author_facet Husen, Sharifah Farhanah Syed
Linn, Kyaw Zaw
Ong, Clara Chong Hui
Huan, Xiaowei
Loo, Liang Hui
Sazali, Ismail Bin
Vasoo, Shawn
Foo, Meow Ling
Ooi, Say Tat
Tan, Thean Yen
Smitasin, Nares
Ling, Moi Lin
Tambyah, Paul Anantharajah
Tan, Seow Yen
Ng, Oon Tek
Marimuthu, Kalisvar
author_sort Husen, Sharifah Farhanah Syed
collection PubMed
description Objectives: The increase in carbapenemase-producing organism (CPO) transmission among hospitalized patients is a growing concern. Studies investigating the transmission of CPO to epidemiologically linked contacts are scarce. We conducted an interim subgroup analysis of the ongoing multicenter household transmission of CPO in Singapore (CaPES-C) study to identify the acquisition rate of CPO among epidemiologically linked contacts of hospitalized CPO patients. Methods: This multicenter prospective cohort study was conducted between January and December 2021. We recruited CPO-positive patients and their epidemiologically linked contacts. Stool samples were collected from the patients at baseline, day 3, day 7, and at weeks 2, 3, 4, 5, 6, 12, 24, 36, and 48. Additionally, a sample was collected at the time of discharge from the hospital. Xpert Carba-R test was used to detect CPO genotypes in the stool samples. In this interim analysis, we calculated the acquisition rate of CPO among the epidemiologically linked hospital contacts of CPO positive patients using Stata version 15 software. Results: We recruited 22 (56.4%) CPO-positive index patients [blaNDM, n = 7 (31.8%); blaIMP, n = 3 (13.6%); blaOXA-48, n = 10 (45.5%), others, n = 2 (9.1%)] and 14 (35.9%) epidemiologically linked hospital contacts. The median age of CPO-positive patients was 72.5 years (IQR, 62–82) and 15 (68.2%) were female. The median age for the epidemiologically linked contacts was 82.5 years (IQR, 70–85) and 4 (28.6%) were female. After 1,082 patient days, 2 (14.3%) epidemiologically linked contacts tested positive for CPO giving an acquisition rate of 1.85 per 1,000 patient days (95% CI, 0.46 – 7.39). One of these participants acquired a concordant genotype (blaOXA-48) at day 7 and the other acquired a discordant genotype (CPO positive index, blaIMP; epidemiologically linked contact, blaNDM) at week 12 of follow-up. Conclusions: This small interim analysis revealed a high conversion rate among epidemiologically linked hospital contacts. A larger study is needed to understand the influence of genotypes, hospital environment, and human behavior on the transmission of CPO in hospitals.
format Online
Article
Text
id pubmed-10571168
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-105711682023-10-14 SG-APSIC1095: Acquisition rate of carbapenemase-producing organisms (CPOs) among hospital contacts of CPO patients: An interim subgroup analysis of a cohort study Husen, Sharifah Farhanah Syed Linn, Kyaw Zaw Ong, Clara Chong Hui Huan, Xiaowei Loo, Liang Hui Sazali, Ismail Bin Vasoo, Shawn Foo, Meow Ling Ooi, Say Tat Tan, Thean Yen Smitasin, Nares Ling, Moi Lin Tambyah, Paul Anantharajah Tan, Seow Yen Ng, Oon Tek Marimuthu, Kalisvar Antimicrob Steward Healthc Epidemiol Multidrug-Resistant (MDR) Organisms Objectives: The increase in carbapenemase-producing organism (CPO) transmission among hospitalized patients is a growing concern. Studies investigating the transmission of CPO to epidemiologically linked contacts are scarce. We conducted an interim subgroup analysis of the ongoing multicenter household transmission of CPO in Singapore (CaPES-C) study to identify the acquisition rate of CPO among epidemiologically linked contacts of hospitalized CPO patients. Methods: This multicenter prospective cohort study was conducted between January and December 2021. We recruited CPO-positive patients and their epidemiologically linked contacts. Stool samples were collected from the patients at baseline, day 3, day 7, and at weeks 2, 3, 4, 5, 6, 12, 24, 36, and 48. Additionally, a sample was collected at the time of discharge from the hospital. Xpert Carba-R test was used to detect CPO genotypes in the stool samples. In this interim analysis, we calculated the acquisition rate of CPO among the epidemiologically linked hospital contacts of CPO positive patients using Stata version 15 software. Results: We recruited 22 (56.4%) CPO-positive index patients [blaNDM, n = 7 (31.8%); blaIMP, n = 3 (13.6%); blaOXA-48, n = 10 (45.5%), others, n = 2 (9.1%)] and 14 (35.9%) epidemiologically linked hospital contacts. The median age of CPO-positive patients was 72.5 years (IQR, 62–82) and 15 (68.2%) were female. The median age for the epidemiologically linked contacts was 82.5 years (IQR, 70–85) and 4 (28.6%) were female. After 1,082 patient days, 2 (14.3%) epidemiologically linked contacts tested positive for CPO giving an acquisition rate of 1.85 per 1,000 patient days (95% CI, 0.46 – 7.39). One of these participants acquired a concordant genotype (blaOXA-48) at day 7 and the other acquired a discordant genotype (CPO positive index, blaIMP; epidemiologically linked contact, blaNDM) at week 12 of follow-up. Conclusions: This small interim analysis revealed a high conversion rate among epidemiologically linked hospital contacts. A larger study is needed to understand the influence of genotypes, hospital environment, and human behavior on the transmission of CPO in hospitals. Cambridge University Press 2023-03-16 /pmc/articles/PMC10571168/ http://dx.doi.org/10.1017/ash.2023.70 Text en © The Society for Healthcare Epidemiology of America 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Multidrug-Resistant (MDR) Organisms
Husen, Sharifah Farhanah Syed
Linn, Kyaw Zaw
Ong, Clara Chong Hui
Huan, Xiaowei
Loo, Liang Hui
Sazali, Ismail Bin
Vasoo, Shawn
Foo, Meow Ling
Ooi, Say Tat
Tan, Thean Yen
Smitasin, Nares
Ling, Moi Lin
Tambyah, Paul Anantharajah
Tan, Seow Yen
Ng, Oon Tek
Marimuthu, Kalisvar
SG-APSIC1095: Acquisition rate of carbapenemase-producing organisms (CPOs) among hospital contacts of CPO patients: An interim subgroup analysis of a cohort study
title SG-APSIC1095: Acquisition rate of carbapenemase-producing organisms (CPOs) among hospital contacts of CPO patients: An interim subgroup analysis of a cohort study
title_full SG-APSIC1095: Acquisition rate of carbapenemase-producing organisms (CPOs) among hospital contacts of CPO patients: An interim subgroup analysis of a cohort study
title_fullStr SG-APSIC1095: Acquisition rate of carbapenemase-producing organisms (CPOs) among hospital contacts of CPO patients: An interim subgroup analysis of a cohort study
title_full_unstemmed SG-APSIC1095: Acquisition rate of carbapenemase-producing organisms (CPOs) among hospital contacts of CPO patients: An interim subgroup analysis of a cohort study
title_short SG-APSIC1095: Acquisition rate of carbapenemase-producing organisms (CPOs) among hospital contacts of CPO patients: An interim subgroup analysis of a cohort study
title_sort sg-apsic1095: acquisition rate of carbapenemase-producing organisms (cpos) among hospital contacts of cpo patients: an interim subgroup analysis of a cohort study
topic Multidrug-Resistant (MDR) Organisms
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571168/
http://dx.doi.org/10.1017/ash.2023.70
work_keys_str_mv AT husensharifahfarhanahsyed sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT linnkyawzaw sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT ongclarachonghui sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT huanxiaowei sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT loolianghui sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT sazaliismailbin sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT vasooshawn sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT foomeowling sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT ooisaytat sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT tantheanyen sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT smitasinnares sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT lingmoilin sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT tambyahpaulanantharajah sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT tanseowyen sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT ngoontek sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy
AT marimuthukalisvar sgapsic1095acquisitionrateofcarbapenemaseproducingorganismscposamonghospitalcontactsofcpopatientsaninterimsubgroupanalysisofacohortstudy